New Stock News | Good Doctor Cloud Medical has submitted its listing application to the Hong Kong Stock Exchange and has provided services to over 660,000 grassroots medical terminal customers.

According to the disclosure on September 30 by the Hong Kong Stock Exchange, Sichuan Haoyisheng Cloud Medical Technology Group Co., Ltd. (referred to as Haoyisheng Cloud Medical) has submitted its listing application to the main board of the Hong Kong Stock Exchange, with HAITONG INT'L and CITIC SEC as joint sponsors. According to the prospectus, Haoyisheng Cloud Medical is a leading comprehensive grassroots medical empowerment platform in China, dedicated to bringing high-quality medical resources down to the grassroots market, allowing grassroots LBX Pharmacy Chain Joint Stock to enjoy the level of medical services and products of tertiary hospitals at their doorstep. According to data from ZHUO SHI Consulting, based on revenue in 2024, the company ranks second in the Chinese grassroots medical empowerment services industry. As of December 31, 2024, based on the number of grassroots medical terminal customers (including (i) grassroots medical institutions covering village health stations, outpatient departments, and clinics, and (ii) grassroots pharmacies covering individual pharmacies and small chain pharmacies), Haoyisheng Cloud Medical ranks second in the Chinese grassroots medical empowerment services industry. The company is also the only comprehensive empowerment platform in the Chinese grassroots medical industry that uses digital intelligence and AI to assist empowerment, providing a business scenario covering solution including inspection, diagnosis, medication, and treatment for grassroots medical institutions. As of June 30, 2025, Haoyisheng Cloud Medical has directly served over 660,600 grassroots medical terminal customers, including over 389,300 grassroots medical institutions and 271,300 grassroots pharmacies, including over 198,900 individual pharmacies and over 72,300 small chain pharmacies. From December 31, 2022 to December 31, 2024, the number of registered grassroots medical terminal customers of the company grew at a compound annual growth rate of 29.0%. As of June 30, 2025, the coverage of grassroots medical terminal customers of Haoyisheng Cloud Medical has expanded to over 99% of the total number of county-level administrative regions in China. The monthly average number of paying customers of the company increased from over 83,800 in 2022 to over 121,900 in 2024, with a compound annual growth rate of 20.6%. The data shows that the Chinese grassroots medical industry is enormous, mainly consisting of grassroots medical terminal constructions (including grassroots medical institutions and grassroots pharmacies) covering the vast sinking market in China. According to data from ZHUO SHI Consulting, as of December 31, 2024, China has approximately 1.636 million grassroots medical terminals, including approximately 1.04 million grassroots medical institutions, 291,000 individual pharmacies, and 304,000 small chain pharmacies. It is estimated that the number of grassroots medical terminals will grow at a compound annual growth rate of 2.3% from 2024 to 2030, reaching 1.871 million by the end of 2030. In 2024, the market size of the Chinese grassroots medical industry reached RMB 545.5 billion in terms of revenue. It is expected that from 2024 to 2030, the market size will grow at a compound annual growth rate of 9.2%, reaching RMB 922.0 billion by the end of 2030. In terms of finances, in the fiscal year 2023, 2024, and the six-month period ended June 30, 2025, the company achieved revenues of approximately RMB 3.065 billion, 3.264 billion, and 1.891 billion respectively; during the same period, the net profits for the year/period were 62.479 million, 37.806 million, and 35.77 million RMB respectively.